SyKoAcTivE

View Original

San Francisco Will Vote On Decriminalizing Psychedelics Next Year

Senator Scott Wiener’s Senate Bill 519, which decriminalizes the possession and personal use of certain psychedelic drugs will be voted on next year. San Francisco Supervisors Dean Preston and Hillary Ronen introduced legislation that would decriminalize use and possession of psilocybin mushrooms, LSD, MDMA, DMT, and Mescaline.

Senator Scott Wiener’s (D-San Francisco) Senate Bill 519, which decriminalizes the possession and personal use of certain psychedelic drugs, will now become a two-year bill. The bill thus remains alive and will be eligible to move forward next year. This groundbreaking legislation moved significantly farther than anticipated — passing the full Senate and passing all of its Assembly policy committees. That said, more time was needed to lay educational groundwork with members and the public to ensure the bill’s success. Delaying full Assembly consideration of the bill until next year will allow the SB 519 coalition of advocates and supporters – which includes veterans who have used psychedelics to treat PTSD, parents whose children overcame addiction with psychedelic therapy, and physicians – to capitalize on the momentum from this year while building support in the Assembly for next year.

Decriminalizing psychedelics remains an urgent issue. Research from top medical universities shows that these substances can have significant benefits, particularly for treating mental health and substance use disorders. Decriminalizing their personal possession and use is part of the larger movement to end the racist War on Drugs and its failed and destructive policies.

“While I’m disappointed we couldn’t pass SB 519 this year, I’m heartened that the bill moved as deep into the process as it did and that we have a realistic chance of passing it next year,” said Senator Wiener. “Given that this idea had never before been introduced in the Legislature, our progress is a testament to the power of the issue and the urgency of the need to act. I’m so grateful to my colleagues for working with us and advancing the bill so significantly. Now that we have more time, I’m optimistic through education and member engagement we can pass this critical legislation next year. Decriminalizing psychedelics is an important step in ending the failed War on Drugs, and we are committed to this fight. Our mental health crisis is worse than ever, and psychedelics have shown great promise in treating mental health issues from PTSD to anxiety and depression. I look forward to working hard to continue this fight.”